Takeda Pharmaceuticals USA, Inc. filed 39 H-1B LCAs in FY2023. Average salary: $159k.
In FY FY2023, Takeda Pharmaceuticals USA, Inc. filed 39 H-1B petitions with an average salary of $159k. Top positions include Operations Support Specialist (5%), Associate Director, Omnichannel Engagement PDT (5%), Computer Network Engineer (5%). Filings were concentrated in Massachusetts (72%), Illinois (18%), Pennsylvania (5%). The certification rate was 95%. Salaries ranged from $72k to $220k.
| Percentile | Salary |
|---|---|
| 10th | $120k |
| 25th | $135k |
| 50th (Median) | $158k |
| 75th | $185k |
| 90th | $200k |
Based on 39 salary records. Range: $72k – $220k.
100% of filings offer salaries above the prevailing wage, with an average premium of 27.4%. The average prevailing wage is $127k (based on 39 filings).
Average processing time is 8 days (median: 7 days). Fastest: 4 days, slowest: 28 days. Based on 38 filings.
13% of filings are for new positions, while 21% are for continued employment (39 filings).
Average contract duration: 36 months (median: 36 months), based on 39 filings.
| Visa Class | Filings |
|---|---|
| H-1B | 38 |
| E-3 AUSTRALIAN | 1 |
| Education Level | Filings |
|---|---|
| Not Specified | 39 |
| Job Title | Filings |
|---|---|
| Operations Support Specialist | 2 |
| Associate Director, Omnichannel Engagement PDT | 2 |
| Computer Network Engineer | 2 |
| Technology Audit Lead | 1 |
| Associate Director, Data Governance and Strategy | 1 |
| Systems Manager | 1 |
| Advanced and Patient Analytics Lead | 1 |
| Government Pricing Analyst | 1 |
| Senior Research Associate II, Oncology Cell Therapy | 1 |
| System Architect-Product Engineer | 1 |
Takeda Pharmaceuticals USA, Inc. filed 39 H-1B Labor Condition Applications (LCAs) in FY2023.
The average H-1B salary at Takeda Pharmaceuticals USA, Inc. in FY2023 was $159k.
The top H-1B job titles sponsored by Takeda Pharmaceuticals USA, Inc. in FY2023 include Operations Support Specialist, Associate Director, Omnichannel Engagement PDT, Computer Network Engineer.